HCPCS Level II drug code
Q0167 — Dronabinol, 2.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
In short
Q0167 is the HCPCS Level II code for dronabinol, 2.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen. CMS assigns NDCs for Dronabinol and Marinol to it. One billing unit is 2.5 mg. The Medicare Part B payment limit is $2.092 per unit (October 1, 2026 through December 31, 2026).
Code
CMS HCPCS file- Descriptor
- Dronabinol, 2.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
- Short descriptor
- Dronabinol 2.5mg oral
- Code set
- HCPCS Level II, maintained by CMS
- Effective
- Apr 1, 1998
The billing unit is read from the descriptor. Confirm it against the CMS file before billing.
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Units and claim line
Units = dose given ÷ 2.5 mg. For example, 250 mg is 100 units. Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.
Enter the dose given to build the claim line.
NDCs billed under Q0167
CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 6 NDCs to Q0167 for Dronabinol and Marinol. Billing units per package are CMS’s figures for this code’s unit.
| Drug | NDC (11-digit) | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| Dronabinol | 00904-7144-61 | Major Pharmaceuticals | 100 | 100 |
| Dronabinol | 00904-7145-04 | Major Pharmaceuticals | 30 | 60 |
| Dronabinol | 53097-0571-60 | ThePharmaNetwork, LLC | 60 | 60 |
| Dronabinol | 67877-0753-60 | Ascend Laboratories, LLC | 60 | 60 |
| Dronabinol | 67877-0754-60 | Ascend Laboratories, LLC | 60 | 120 |
| Marinol | 67877-0755-60 | Ascend Laboratories, LLC | 60 | 240 |
Q0167: common questions
- Is Q0167 a CPT code?
- No. Q0167 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
- What NDCs are billed under Q0167?
- CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 6 NDCs under Q0167, for Dronabinol and Marinol. The table on this page shows each one with its billing units per package.
- What is the Medicare payment limit for Q0167?
- $2.092 per 2.5 mg, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.
- What is one billing unit of Q0167?
- One unit of Q0167 is 2.5 mg, as stated in the code's descriptor. Units to report = dose given ÷ 2.5 mg. J-code billing units.